Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine that addresses high unmet medical needs for a rare ...

Data Readout Expected Early Calendar 2025; NDA Submission on Track for 1H Calendar 2025PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, ...

Pomalidomide, a cancer medication, has been revealed in a clinical trial to be safe and efficacious in treating hereditary hemorrhagic telangiectasia ... unknown about the mechanisms of HHT ...

Hereditary hemorrhagic telangiectasia (HHT ... Since pomalidomide and bevacizumab may have different mechanisms of action, they may have additive or synergistic activity in severe cases of ...

Purpose Patients with non-proliferative macular telangiectasia type 2 (MacTel) have ganglion cell layer (GCL) and nerve fibre layer (NFL) loss, but it is unclear whether the thinning is progressive.

In the former bank building in the town square of Potamos, Kythera, you can explore a permanent and captivating exhibition dedicated to the world-famous Antikythera Mechanism. This exhibition is open ...

This information is intended for healthcare professionals in the EU. At the 2024 European Association of Neurology (EAN) Congress, one satellite symposium discussed the recognition, diagnosis, and ...

Researchers uncover shared cellular mechanisms across three major dementias. ScienceDaily . Retrieved October 3, 2024 from www.sciencedaily.com / releases / 2024 / 09 / 240911112134.htm ...

Human 'molecular map' contributes to the understanding of disease mechanisms. ScienceDaily . Retrieved October 3, 2024 from www.sciencedaily.com / releases / 2024 / 09 / 240911175947.htm ...